Journal of Clinical and Translational Science
April 1, 2026
T. Millay, Monica Bhargavi Kodali, Linda B. Cottler
Objectives/Goals: Mainstream interest in psilocybin (“shrooms”) has grown over the past several years as two US states have “legalized” psilocybin and clinical trials are underway for use in multiple mental health conditions. We evaluated self-reported use of psilocybin among community members in North Florida and trends in use from 2012 to the present. Methods/Study Population: Established in...
Substance Use & Misuse
June 5, 2025
Anna Wang, Ryan Athay, Nae Won et al.
2 citations
Venue intercept survey method detected signals of recreational cannabis, psilocybin, and cocaine use in the 20 US urban cities visited over a weekend. Reported prevalence differed by region. This suggests that prevention messaging should be tailored to the specific US regions.
Drug and Alcohol Dependence
May 1, 2024
Joseph J Palamar, Nicole D. Fitzgerald, Thomas H Carr et al.
9 citations
Psilocybin, the principle psychoactive component in "shrooms", is regaining acceptance in therapeutic settings, leading to media coverage of medical benefits associated with use. Possession is also becoming increasingly decriminalized throughout the United States. There is a lack of data on prevalence of shroom use, but trends in law enforcement seizure data can provide one indicator of shroom...
Journal of Psychopharmacology
August 2023
Joseph J Palamar, Nicole D. Fitzgerald, David J Grundy et al.
The use of ketamine, a controlled dissociative anesthetic, has become more widespread in recent years with recreational/nonmedical use increasing and ketamine becoming more widely available in clinics to treat depression. We examined recent trends in adverse effects related to ketamine use. US National Poison Control data were examined, focusing on ketamine exposures among those aged ⩾13...
Journal of Food and Drug Analysis
March 15, 2021
Wen-Jing Yu, Linda B. Cottler, Jih-Heng Li
13 citations
Use of New Psychoactive Substances (NPS) has posed a global threat to public health and the security of the population. As of December 2019, the NPS items identified in total have outnumbered by three to one the controlled substances listed in the 1961 and 1971 UN Drug Conventions. However, most of these NPS have not been scheduled by the United Nations because of their easy modification on the...
Addiction
August 4, 2009
Linda B. Cottler, Kit Sang Leung, Arbi Ben Abdallah
56 citations
ABSTRACT Aims This study evaluated the prevalence and reliability of DSM‐IV adopted criteria for 3,4‐methylenedioxymethamphetamine (MDMA) abuse and dependence with a purpose to determine whether it is best conceptualized within the category of hallucinogens, amphetamines or its own category. Design Test–re‐test study. Participants MDMA users (life‐time use >5 times) were recruited in St Louis,...
Journal of ethnicity in substance abuse
2008
Kit Sang Leung, Jih-Heng Li, Wen-Ing Tsay et al.
Research among Asian users of methylenedioxy methamphetamine (MDMA), also known as Ecstasy, is rare. To evaluate the feasibility of a study on the abuse of and dependence on Ecstasy, two focus groups of users (n= 12) and health professionals (n=7) were conducted in Taiwan. Major results included blatant human testing with "candy and dinosaur girls" and a specific sequence of drugs called a...